These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 20668658)

  • 1. Integrative genomic analyses identify BRF2 as a novel lineage-specific oncogene in lung squamous cell carcinoma.
    Lockwood WW; Chari R; Coe BP; Thu KL; Garnis C; Malloff CA; Campbell J; Williams AC; Hwang D; Zhu CQ; Buys TP; Yee J; English JC; Macaulay C; Tsao MS; Gazdar AF; Minna JD; Lam S; Lam WL
    PLoS Med; 2010 Jul; 7(7):e1000315. PubMed ID: 20668658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA polymerase III transcription in cancer: the BRF2 connection.
    Cabarcas S; Schramm L
    Mol Cancer; 2011 Apr; 10():47. PubMed ID: 21518452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Divergent genomic and epigenomic landscapes of lung cancer subtypes underscore the selection of different oncogenic pathways during tumor development.
    Lockwood WW; Wilson IM; Coe BP; Chari R; Pikor LA; Thu KL; Solis LM; Nunez MI; Behrens C; Yee J; English J; Murray N; Tsao MS; Minna JD; Gazdar AF; Wistuba II; MacAulay CE; Lam S; Lam WL
    PLoS One; 2012; 7(5):e37775. PubMed ID: 22629454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of the TFIIIB subunits Brf1 and Brf2 in cancer cells.
    Cabarcas S; Jacob J; Veras I; Schramm L
    BMC Mol Biol; 2008 Aug; 9():74. PubMed ID: 18700021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of cell-type specific profiles in tissues and isolated cells from squamous cell carcinomas of the lung.
    Hawthorn L; Stein L; Panzarella J; Loewen GM; Baumann H
    Lung Cancer; 2006 Aug; 53(2):129-42. PubMed ID: 16757060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Landscape of somatic allelic imbalances and copy number alterations in human lung carcinoma.
    Staaf J; Isaksson S; Karlsson A; Jönsson M; Johansson L; Jönsson P; Botling J; Micke P; Baldetorp B; Planck M
    Int J Cancer; 2013 May; 132(9):2020-31. PubMed ID: 23023297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of TFIIB-related factor 2 is significantly correlated with tumor angiogenesis and poor survival in patients with esophageal squamous cell cancer.
    Lu M; Tian H; Yue W; Li L; Li S; Qi L; Hu W; Gao C; Si L
    Med Oncol; 2013 Jun; 30(2):553. PubMed ID: 23550276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Claudin-3 Inhibits Lung Squamous Cell Carcinoma Cell Epithelial-mesenchymal Transition and Invasion via Suppression of the Wnt/β-catenin Signaling Pathway.
    Che J; Yue D; Zhang B; Zhang H; Huo Y; Gao L; Zhen H; Yang Y; Cao B
    Int J Med Sci; 2018; 15(4):339-351. PubMed ID: 29511369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TFIIB-related factor 2 over expression is a prognosis marker for early-stage non-small cell lung cancer correlated with tumor angiogenesis.
    Lu M; Tian H; Yue W; Li L; Li S; Qi L; Hu W; Gao C; Si L
    PLoS One; 2014; 9(2):e88032. PubMed ID: 24523874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of genes involved in squamous cell carcinoma of the lung using synchronized data from DNA copy number and transcript expression profiling analysis.
    Lo KC; Stein LC; Panzarella JA; Cowell JK; Hawthorn L
    Lung Cancer; 2008 Mar; 59(3):315-31. PubMed ID: 18029052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of structural genetics of non-schistosoma-associated squamous cell carcinoma of the urinary bladder.
    Molitor M; Junker K; Eltze E; Toma M; Denzinger S; Siegert S; Knuechel R; Gaisa NT
    Int J Clin Exp Pathol; 2015; 8(7):8143-58. PubMed ID: 26339383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profiling of cultured human bronchial epithelial and lung carcinoma cells.
    Hellmann GM; Fields WR; Doolittle DJ
    Toxicol Sci; 2001 May; 61(1):154-63. PubMed ID: 11294986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRF2 as a promising indicator for radical lymph-node dissection surgery in patients with cN0 squamous cell carcinoma of the middle thoracic esophagus.
    Tian Y; Wang C; Lu M
    Surg Today; 2019 Feb; 49(2):158-169. PubMed ID: 30182305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A meta-analysis of BRF2 as a prognostic biomarker in invasive breast carcinoma.
    Cabarcas-Petroski S; Meneses PI; Schramm L
    BMC Cancer; 2020 Nov; 20(1):1093. PubMed ID: 33176745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of proto-oncogene BRF2 in breast cancer cells by the dietary soybean isoflavone daidzein.
    Koo J; Cabarcas-Petroski S; Petrie JL; Diette N; White RJ; Schramm L
    BMC Cancer; 2015 Nov; 15():905. PubMed ID: 26573593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex determining region Y-Box 2 (SOX2) is a potential cell-lineage gene highly expressed in the pathogenesis of squamous cell carcinomas of the lung.
    Yuan P; Kadara H; Behrens C; Tang X; Woods D; Solis LM; Huang J; Spinola M; Dong W; Yin G; Fujimoto J; Kim E; Xie Y; Girard L; Moran C; Hong WK; Minna JD; Wistuba II
    PLoS One; 2010 Feb; 5(2):e9112. PubMed ID: 20161759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of transcriptional subtypes in lung adenocarcinoma and squamous cell carcinoma through integrative analysis of microarray and RNA sequencing data.
    Fauteux F; Surendra A; McComb S; Pan Y; Hill JJ
    Sci Rep; 2021 Apr; 11(1):8709. PubMed ID: 33888829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing of BRF2 inhibits the growth and metastasis of lung cancer cells.
    Bian Y; Li Q; Li Q; Pan R
    Mol Med Rep; 2020 Sep; 22(3):1767-1774. PubMed ID: 32705258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-function analysis of the human TFIIB-related factor II protein reveals an essential role for the C-terminal domain in RNA polymerase III transcription.
    Saxena A; Ma B; Schramm L; Hernandez N
    Mol Cell Biol; 2005 Nov; 25(21):9406-18. PubMed ID: 16227591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Landscape of Actionable Molecular Alterations in Immunomarker-Defined Large-Cell Carcinoma of the Lung.
    Chan AW; Chau SL; Tong JH; Chow C; Kwan JSH; Chung LY; Lung RW; Tong CY; Tin EK; Law PP; Law WT; Ng CSH; Wan IYP; Mok TSK; To KF
    J Thorac Oncol; 2019 Jul; 14(7):1213-1222. PubMed ID: 30978501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.